Showing 105 of 105on this page. Filters & sort apply to loaded results; URL updates for sharing.105 of 105 on this page
Cardurion Pharmaceuticals Licenses Clinical Stage Heart Failure ...
Cardurion Pharmaceuticals Further Bolsters Leadership Team with ...
Cardurion 2026 Company Profile: Valuation, Funding & Investors | PitchBook
Cardurion Pharmaceuticals Welcomes Emma Reeve as Independent Board ...
Cardurion Pharmaceuticals Presents Positive Clinical Results from ...
Cardurion - 2026 Company Profile, Team, Funding & Competitors - Tracxn
Transforming the treatment of cardiovascular disease | Cardurion
Cardurion Pharmaceuticals Selected as an Endpoints 11 Most Promising ...
Cardurion Pharmaceuticals Raises $260 Million Series B Funding
Endpoints 11 winner Cardurion Pharmaceuticals: A shot at one of heart ...
Cardurion Pharmaceuticals | LinkedIn
#onecardurion | Cardurion Pharmaceuticals
Medtech Alert on LinkedIn: Cardurion Pharmaceuticals Further Bolsters ...
Cardurion Pharma (www.cardurion.com), a pharma company focused on heart ...
Cardurion Pharmaceuticals on LinkedIn: #onecardurion
Cardurion Pharmaceuticals on LinkedIn: #heartfailure # ...
Cardurion Pharmaceuticals Patents - Insights & Stats
Karen Lewis Appointed as Chief People Officer at Cardurion ...
#teamtime | Cardurion Pharmaceuticals
Cardurion Pharmaceuticals on LinkedIn: #cardiovascular #innovation # ...
PDE9 - Cardurion
Our Science - Cardurion
Cardurion Raises $260M to Advance Cardiovascular Assets - BioSpace
CaMKII - Cardurion
Patients - Cardurion
CARDURION PHARMA Trademark of Cardurion Pharmaceuticals, Inc ...
Careers and Culture - Cardurion
Cardurion touts Phase 2 data for PDE9 inhibitor in heart failure, plans ...
Cardurion Completes Enrollment in Phase 2 Trials for Novel Heart ...
Cardurion Builds Cardiovascular Pipeline with $260M Series B Financing ...
Cardurion is positioned for our next stage of growth, fueled by a ...
Cardurion concludes enrolment in Phase II trials for HF treatment
Research and Development - Cardurion
About Cardurion - Cardurion
Website Style Guide - Cardurion
Cardurion closes $260m in Series B to develop cardiovascular pipeline
Cardurion raises another $260M to fuel heart drug pipeline | BioPharma Dive
Cardurion concludes enrolment in Phase II trials for heart failure ...
Congratulations to Metsera and Cardurion Pharmaceuticals on being named ...
Cardurion Pharmaceuticals on LinkedIn: #onecardurion #happyholidays
Cardio-focused Cardurion raises hearty $260M series B
#heartfailure #cardiovasculardisease #cvdruginnovation | Cardurion ...
Cardurion Pharmaceuticals raises $260 Million Series B Financing - YouTube
#cvinnovation | Cardurion Pharmaceuticals
Leadership - Cardurion
Healthcare Providers - Cardurion
Cardurion Pharmaceuticals Secures $260 Million Series B Financing to ...
Cardurion Pharmaceuticals | Bain Capital Life Sciences
#jpm24 | Cardurion Pharmaceuticals
Steve Migausky - Cardurion
Elizabeth Radcliffe - CFO at Cardurion Pharmaceuticals | The Org
#happyholidays | Cardurion Pharmaceuticals
Cardurion Pharmaceuticals on LinkedIn: Thank you Nasdaq for recognizing ...
Custom Stories Archive - Cardurion
Cardurion Pharmaceuticals on LinkedIn: #juneteenth #diversity # ...
Cardurion Pharmaceuticals on LinkedIn: #biotech #cardiovascular #innovation
Kenneth Novack - Cardurion
Cardurion begins subject dosing in heart failure treatment trial
카두리온, 시리즈B 2.6억弗..‘PDE9 저해제’ 심부전 개발 - 바이오스펙테이터
Interested in joining a fun team working at the forefront of ...
心血管疾患の治療のための新しい次世代治療薬を開発する"Cardurion Pharmaceuticals"がSeries Bで$260Mを調達 ...
#cardiovasculardisease #heartfailure #cvdruginnovation #onecardurion ...
#heartfailure #cardiovasculardisease #cvdruginnovation #onecardurion ...
#cardurionpharma #hearthealth #innovation #aim #aimhigh #whatsuraim ...
#esccongress #heartfailure #cardiovasculardisease #cvdruginnovation ...
Promising Phase 2a Results for Cardurion's Heart Failure Treatment
#worldheartday #cardiovasculardisease #heartfailure #cvdruginnovation # ...
So thrilled to welcome Karen Lewis to Cardurion! | Elizabeth Radcliffe
心血管疾病治疗药物研发商Cardurion获得2.6亿美元B轮融资，为心脏药物管道提供资金-动脉网
.jpg){kind=logo}
